Literature DB >> 8506946

Simian immunodeficiency virus infection of the gastrointestinal tract of rhesus macaques. Functional, pathological, and morphological changes.

C Heise1, P Vogel, C J Miller, C H Halsted, S Dandekar.   

Abstract

Gastrointestinal dysfunction and wasting are frequent complications of human immunodeficiency virus (HIV) infection. Nutrient malabsorption, decreased digestive enzymes and HIV transcripts have been documented in jejunal mucosa of HIV-infected patients; however, the pathogenesis of this enteropathy is not understood. Rhesus macaques infected with simian immunodeficiency virus (SIV) also exhibit diarrhea and weight loss; therefore, we investigated the use of this animal model to study HIV-associated intestinal abnormalities. A retrospective study of intestinal tissues from 15 SIV-infected macaques was performed to determine the cellular targets of the virus and examine the effect of SIV infection on jejunal mucosal morphology and function. Pathological and morphological changes included inflammatory infiltrates, villus blunting, and crypt hyperplasia. SIV-infected cells were detected by in situ hybridization in stomach, duodenum, jejunum, ileum, cecum, and colon. Using combined immunohistochemistry and in situ hybridization, the cellular targets were identified as T lymphocytes and macrophages. The jejunum of SIV-infected animals had depressed digestive enzyme activities and abnormal morphometry, suggestive of a maturational defect in proliferating epithelial cells. Our results suggest that SIV infection of mononuclear inflammatory cells in intestinal mucosa may alter development and function of absorptive epithelial cells and lead to jejunal dysfunction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8506946      PMCID: PMC1887002     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  54 in total

1.  Intestinal infections in patients with the acquired immunodeficiency syndrome (AIDS). Etiology and response to therapy.

Authors:  P D Smith; H C Lane; V J Gill; J F Manischewitz; G V Quinnan; A S Fauci; H Masur
Journal:  Ann Intern Med       Date:  1988-03       Impact factor: 25.391

2.  Long-term persistent infection of macaque monkeys with the simian immunodeficiency virus.

Authors:  M D Daniel; N L Letvin; P K Sehgal; G Hunsmann; D K Schmidt; N W King; R C Desrosiers
Journal:  J Gen Virol       Date:  1987-12       Impact factor: 3.891

Review 3.  Metabolic disturbances and wasting in the acquired immunodeficiency syndrome.

Authors:  C Grunfeld; K R Feingold
Journal:  N Engl J Med       Date:  1992-07-30       Impact factor: 91.245

4.  Detection of HIV-1 RNA in the lamina propria of patients with AIDS and gastrointestinal disease.

Authors:  C H Fox; D Kotler; A Tierney; C S Wilson; A S Fauci
Journal:  J Infect Dis       Date:  1989-03       Impact factor: 5.226

5.  Lymphadenopathy in macaques experimentally infected with the simian immunodeficiency virus (SIV).

Authors:  L V Chalifoux; D J Ringler; N W King; P K Sehgal; R C Desrosiers; M D Daniel; N L Letvin
Journal:  Am J Pathol       Date:  1987-07       Impact factor: 4.307

6.  Inoculation of baboons and macaques with simian immunodeficiency virus/Mne, a primate lentivirus closely related to human immunodeficiency virus type 2.

Authors:  R E Benveniste; W R Morton; E A Clark; C C Tsai; H D Ochs; J M Ward; L Kuller; W B Knott; R W Hill; M J Gale
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

7.  Necropsy findings in rhesus monkeys experimentally infected with cultured simian immunodeficiency virus (SIV)/delta.

Authors:  G B Baskin; M Murphey-Corb; E A Watson; L N Martin
Journal:  Vet Pathol       Date:  1988-11       Impact factor: 2.221

8.  Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms.

Authors:  J A Nelson; C A Wiley; C Reynolds-Kohler; C E Reese; W Margaretten; J A Levy
Journal:  Lancet       Date:  1988-02-06       Impact factor: 79.321

9.  Lymphocytes isolated from the intestinal lamina propria of normal nonhuman primates have increased expression of genes associated with T-cell activation.

Authors:  M Zeitz; W C Greene; N J Peffer; S P James
Journal:  Gastroenterology       Date:  1988-03       Impact factor: 22.682

10.  Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.

Authors:  P F Piguet; G E Grau; B Allet; P Vassalli
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

View more
  37 in total

1.  Differential effects of simian immunodeficiency virus infection on immune inductive and effector sites in the rectal mucosa of rhesus macaques.

Authors:  M Vajdy; R S Veazey; H K Knight; A A Lackner; M R Neutra
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

Review 2.  Pathogenesis of HIV in the gastrointestinal tract.

Authors:  Satya Dandekar
Journal:  Curr HIV/AIDS Rep       Date:  2007-02       Impact factor: 5.071

3.  Induction of lymphocyte proliferation and severe gastrointestinal disease in macaques by a nef gene variant SIVmac239.

Authors:  V G Sasseville; Z Du; L V Chalifoux; D R Pauley; H L Young; P K Sehgal; R C Desrosiers; A A Lackner
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

4.  The HIV-1-specific protein Casp8p41 induces death of infected cells through Bax/Bak.

Authors:  Amy M Sainski; Sekar Natesampillai; Nathan W Cummins; Gary D Bren; Julie Taylor; Dyana T Saenz; Eric M Poeschla; Andrew D Badley
Journal:  J Virol       Date:  2011-06-08       Impact factor: 5.103

5.  Expression of simian immunodeficiency virus nef in immune cells of transgenic mice leads to a severe AIDS-like disease.

Authors:  Marie-Chantal Simard; Pavel Chrobak; Denis G Kay; Zaher Hanna; Serge Jothy; Paul Jolicoeur
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

6.  Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy-treated macaques.

Authors:  Philip J Santangelo; Kenneth A Rogers; Chiara Zurla; Emmeline L Blanchard; Sanjeev Gumber; Karen Strait; Fawn Connor-Stroud; David M Schuster; Praveen K Amancha; Jung Joo Hong; Siddappa N Byrareddy; James A Hoxie; Brani Vidakovic; Aftab A Ansari; Eric Hunter; Francois Villinger
Journal:  Nat Methods       Date:  2015-03-09       Impact factor: 28.547

Review 7.  HIV infection and the gastrointestinal immune system.

Authors:  J M Brenchley; D C Douek
Journal:  Mucosal Immunol       Date:  2008-01       Impact factor: 7.313

Review 8.  Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection.

Authors:  Zdenek Hel; Elizabeth Stringer; Jiri Mestecky
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

9.  Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration.

Authors:  Sumathi Sankaran; Michael D George; Elizabeth Reay; Moraima Guadalupe; Jason Flamm; Thomas Prindiville; Satya Dandekar
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

10.  Preliminary in vivo efficacy studies of a recombinant rhesus anti-alpha(4)beta(7) monoclonal antibody.

Authors:  L E Pereira; N Onlamoon; X Wang; R Wang; J Li; K A Reimann; F Villinger; K Pattanapanyasat; K Mori; A A Ansari
Journal:  Cell Immunol       Date:  2009-06-26       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.